Beasley Allen has one of the largest and most technologically advanced Mass Torts practices in the country. The Mass Torts division represents numerous people in claims against companies that manufacture and/or market defective pharmaceuticals and/or medical devices. The resources devoted to this division allow the firm to competently and conscientiously handle any group of cases, no matter how large, along with particular catastrophic injury cases.
Our firm was recently involved in one of the greatest victories in Mass Torts history, against drug manufacturer Merck regarding the drug Vioxx. After more than five years of hard-fought and difficult litigation, Merck agreed to pay $4.85 billion, the largest pharmaceutical settlement in U.S. history, to resolve certain Vioxx-related claims involving plaintiffs who suffered a heart attack, including sudden cardiac death, or a stroke.
A new weight loss treatment is available to obese patients but researchers warn the drug has been linked to serious side effects, including cancer risks. The new iinjectable obesity drug, Saxenda, was approved late last year by the Food and Drug Administration (FDA) for patients with a BMI of 30 or more, or for patients with a BMI of 27 with at least one other weight-related condition, such as high blood pressure. The active ingredient, liraglutide, is the same drug in the type 2 diabetes treatment Victoza. Saxenda, however, contains a higher dose than Victoza. New patients will be required ... Read More
Pharmaceutical company Lipocine Inc. is poised to gain Food and Drug Administration (FDA) approval for LPCI 1021, the first swallowable oral testosterone treatment that investors say could make the company’s shares rise more than 80 percent of all goes smoothly. Testosterone treatments generally come in topical gels or patches that deliver testosterone through the skin, or injections that are administered with a shot. The gels are the most popular version though they carry a black box warning because they can be unintentionally transferred to women, children and pets. Thus, an oral version of testosterone would be more convenient than other ... Read More
Jonel Davis-Johnson underwent a thorough cancer screening, which turned out negative, before she underwent a power morcellation procedure in June 2012 for a hysterectomy to remove uterine fibroids. Her husband Arthur claims the operation ultimately killed her. Power morcellatiors are a type of surgical tool that is fitted with a blade that minces entire uteruses or uterine fibroids within the body and removes them through a small incision in the abdomen. The procedures have been favored over open surgeries by many doctors in years past because they are less invasive, leave less scar tissue and offer less recovery time. About ... Read More
People with pacemakers are advised to keep a safe distance from smartphones and mobile phones to avoid unwanted painful shocks or pauses in function, medical device manufacturers and the Food and Drug Administration (FDA) warn. Pacemakers and other implantable cardioverter-defibrillators (ICDs) are small devices that are placed in the chest or abdomen to help control abnormal heart rhythms by using electrical pulses to prompt the heart to beat at a normal rate. Studies from a decade ago have found that pacemakers can sometimes mistakenly detect electromagnetic interference, or EMIs, from smartphones and mobile devices as a cardiac signal that can ... Read More
People with hypothyroidism are at an increased risk of type 2 diabetes; however, people with subclinical hypothyroidism, or the earlier stages of the condition, are only at increased risk of developing diabetes if they are using cholesterol-lowering statin drugs, according to new research. Researchers with the Israel Institute of Technology and other institutions conducted a two-phase investigation that included analyzing electronic medical data from more than 20,000 patients with diabetes who began statin treatment from 2004 to 2005 who were randomly matched to nearly twice as many non-statin users. Patients were followed until December 2010. Researchers evaluated to cohorts for thyroid ... Read More
Reported health problems – including at least four deaths – not listed on the safety label of the implantable permanent birth control Essure have prompted the Food and Drug Administration (FDA) to conduct an investigation into the safety of the devices. Essure is a nonsurgical permanent birth control implant shaped in a spiral that is inserted through the cervix and through the uterus into the fallopian tubes to block fertilization. Bayer Healthcare’s unit Conceptus Inc., received FDA approval to market the device in 2002. Since then, nearly 5,100 reports of complications have been associated with the device, including four deaths. ... Read More
Attorneys for six women suing Johnson & Johnson over injuries they claim to have suffered after undergoing gynecological procedures with the company’s power morcellator device have filed a request with the U.S. Judicial Panel on Multidistrict Litigation to consolidate with at least 22 similar lawsuits pending in 16 different federal district courts. The motion seeks to transfer the cases to U.S. District Judge Kathryn Vratil in Kansas. The request comes just weeks after the Wall Street Journal reported that Johnson & Johnson was being investigated by the Federal Bureau of Investigation (FBI) about how much the company knew about cancer ... Read More
Medtronic is recalling tracheostomy tubes for neonatal and pediatric patients after 12 serious patient injury reports. The tubes, used during tracheostomy procedures to help provide an airway and facilitate the ability to breathe, were formed with a wider-angle bend than standard models, which have caused complications in patients including breathing difficulties that impacted oxygen levels or discomfort. The affected devices include eight product lines of Medtronic Covidien Shiley tracheostomy tubes manufactured after Nov. 29, 2012. Medtronic has informed hospitals and distributors worldwide of the recall and instructed them to notify the primary care physician and the homecare provider that the ... Read More
A law firm is going head-to-head with the Food and Drug Administration (FDA) over documents the agency refused to make public about specific side effects in children taking the antipsychotic drug Risperdal. Sheller PC claims it was stifled in its efforts to advocate on behalf of children injured by Risperdal when it was barred from turning over to the FDA confidential documents it had obtained through discovery in litigation against the makers of the drug. The firm petitioned the FDA in November to change the safety labels on Risperdal and revoke its pediatric indication because of reports that the drug caused ... Read More
A Redmond, Ore., physician could lose her license and be fined thousand of dollars for a long list of violations including prescribing unnecessary and excessive testosterone treatments to a man who developed side effects. The Oregon Medical Review Board’s report claims Dr. Rose Kenny, a family practice physician at a Family Care Center was “grossly negligent” in her treatment of patients. In one case, she over prescribed narcotics to a truck driver who reported having six alcoholic drinks per day. She also prescribed excessive and contraindicated medication to treat diaper rash, and doled out several months of antibiotics to pediatric ... Read More